A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/4745 (2006.01) A61K 31/47 (2006.01) A61P 25/28 (2006.01) A61K 31/27 (2006.01) A61K 31/395 (2006.01) A61K 31/405 (2006.01)
Patent
CA 2323458
The invention relates to the identification of pharmacological agents to be used in the treatment of Alzheimer's disease and related pathological conditions and compositions for treatment of conditions caused by amyloidosis, A.beta.-mediated formation of ROS, or both, such as Alzheimer's disease, are disclosed.
L'invention concerne l'identification d'agents pharmacologiques destinés à être utilisés pour traiter la maladie d'Alzheimer ainsi que les troubles pathologiques liés à celle-ci. L'invention concerne également des compositions permettant de traiter les dysfonctionnements provoqués par l'amylose, par la formation de ROS à médiation A beta , ou par les deux, par exemple la maladie d'Alzheimer.
Atwood Craig S.
Bush Ashley I.
Huang Xudong
Tanzi Rudolph E.
Borden Ladner Gervais Llp
The General Hospital Corporation
LandOfFree
Metal chelators for use in the treatment of alzheimer's disease does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Metal chelators for use in the treatment of alzheimer's disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Metal chelators for use in the treatment of alzheimer's disease will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1364661